SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2022-01-22 05:50
Tx date 2022-01-18
$VMD
Viemed Healthcare, Inc.
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
Rights - Restricted Stock Units (Shares Only)
56 - Grant of rights

+56,937 vol
56,937
Filed 2022-01-22 05:49
Tx date 2017-12-21
$VMD
Viemed Healthcare, Inc.
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
Rights - Restricted Stock Units (Shares Only)
00 - Opening Balance-Initial SEDI Report
Filed 2022-01-22 05:49
Tx date 2022-01-18
$VMD
Viemed Healthcare, Inc.
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+85,410 vol
700,432
Filed 2021-12-31 13:48
Tx date 2017-07-21
$PRG
Precipitate Gold Corp.
Moore, Michael Peter
5 - Senior Officer of Issuer
Direct Ownership
Warrants
55 - Expiration of warrants

-154,000 vol
-77,000
Filed 2021-12-31 13:33
Tx date 2021-12-30
$PRG
Precipitate Gold Corp.
Moore, Michael Peter
5 - Senior Officer of Issuer
Direct Ownership
Warrants
11 - Acquisition or disposition carried out privately
$7,500
+50,000 vol
$0.15 each
50,000
Filed 2021-12-31 13:32
Tx date 2021-12-30
$PRG
Precipitate Gold Corp.
Moore, Michael Peter
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$10,000
+100,000 vol
$0.10 each
649,666
Filed 2021-11-17 14:04
Tx date 2021-11-16
$SR
Strategic Resources Inc.
Moore, Michael Peter
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$31,499
+90,000 vol
$0.35 each
440,000
Filed 2021-10-20 11:58
Tx date 2021-10-18
$PRG
Precipitate Gold Corp.
Moore, Michael Peter
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$47,500
+500,000 vol
$0.095 each
1,050,000
Filed 2021-10-17 12:37
Tx date 2021-10-13
$PRG
Precipitate Gold Corp.
Moore, Michael Peter
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options
$-50,000
-200,000 vol
$0.25 each
550,000
Filed 2021-10-17 12:36
Tx date 2021-03-04
$PRG
Precipitate Gold Corp.
Moore, Michael Peter
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options
$-30,000
-250,000 vol
$0.12 each
750,000
Filed 2021-02-01 21:30
Tx date 2021-01-29
$PRG
Precipitate Gold Corp.
Moore, Michael Peter
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$105,000
+500,000 vol
$0.21 each
1,000,000
Filed 2021-02-01 19:13
Tx date 2021-01-29
$
Archer Exploration Corp.
Moore, Michael Peter
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
5,000
Filed 2021-01-26 16:21
Tx date 2021-01-21
$VMD
Viemed Healthcare, Inc.
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+120,584 vol
615,022
Filed 2021-01-08 21:23
Tx date 2021-01-05
$VMD
Viemed Healthcare, Inc.
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market

-30,917 vol
1,805,809
Filed 2021-01-08 21:23
Tx date 2021-01-05
$VMD
Viemed Healthcare, Inc.
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$780,049
+99,243 vol
$7.86 each
1,836,726
Filed 2021-01-08 21:22
Tx date 2021-01-05
$VMD
Viemed Healthcare, Inc.
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-99,243 vol
0
Filed 2020-11-20 19:01
Tx date 2020-11-19
$SR
Strategic Resources Inc.
Moore, Michael Peter
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$40,700
+110,000 vol
$0.37 each
350,000
Filed 2020-06-26 08:59
Tx date 2020-06-23
$VMD
Viemed Healthcare, Inc.
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-10,431.63
-900 vol
$11.59 each
1,737,483
Filed 2020-06-22 18:01
Tx date 2020-06-22
$VMD
Viemed Healthcare, Inc.
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-1,281,701.928
-108,582 vol
$11.80 each
1,738,383
Filed 2020-06-22 17:59
Tx date 2020-06-19
$VMD
Viemed Healthcare, Inc.
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-1,696,898.576
-144,836 vol
$11.72 each
1,846,965
Filed 2020-05-27 16:56
Tx date 2020-05-25
$PRG
Precipitate Gold Corp.
Moore, Michael Peter
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$75,000
+500,000 vol
$0.15 each
500,000
Filed 2020-05-27 16:55
Tx date 2012-04-03
$PRG
Precipitate Gold Corp.
Moore, Michael Peter
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-05-19 12:11
Tx date 2020-05-14
$VMD
Viemed Healthcare, Inc.
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-498,050
-50,000 vol
$9.96 each
1,991,801
Filed 2020-05-19 12:10
Tx date 2020-05-14
$VMD
Viemed Healthcare, Inc.
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$372,500
+50,000 vol
$7.45 each
2,041,801
Filed 2020-05-19 12:09
Tx date 2020-05-14
$VMD
Viemed Healthcare, Inc.
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options

-50,000 vol
494,438
Filed 2020-05-08 11:47
Tx date 2020-05-06
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Moore, Michael
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other
$
+$13,737 vol
$4.87 each
$515,154
Filed 2020-03-09 10:17
Tx date 2019-12-13
$ONC
Oncolytics Biotech Inc.
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$50,750
+35,000 vol
$1.45 each
87,893
Filed 2019-12-18 15:52
Tx date 2019-12-13
$ONC
Oncolytics Biotech Inc.
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$50,750
+35,000 vol
$1.45 each
Filed 2020-02-21 15:57
Tx date 2020-02-20
$ONC
Oncolytics Biotech Inc.
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+4,210 vol
9,315
Filed 2020-02-21 15:56
Tx date 2020-02-20
$ONC
Oncolytics Biotech Inc.
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
Rights Performance Share Units
57 - Exercise of rights

-4,210 vol
0
Filed 2020-01-27 22:43
Tx date 2020-01-17
$VMD
Viemed Healthcare, Inc.
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+156,673 vol
544,438
Filed 2020-01-10 22:36
Tx date 2020-01-06
$VMD
Viemed Healthcare, Inc.
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-252,149.04
-31,284 vol
$8.06 each
1,991,801
Filed 2020-01-09 23:07
Tx date 2020-01-04
$VMD
Viemed Healthcare, Inc.
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$799,898
+99,243 vol
$8.06 each
2,023,085
Filed 2020-01-09 23:07
Tx date 2020-01-04
$VMD
Viemed Healthcare, Inc.
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-99,243 vol
99,243
Filed 2020-01-02 16:48
Tx date 2019-12-31
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Moore, Michael
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other
$
+$13,965 vol
$1.16 each
$501,417
Filed 2019-12-18 15:52
Tx date 2019-12-13
$ONC
Oncolytics Biotech Inc.
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$50,750
+35,000 vol
$1.45 each
87,893
Filed 2019-11-11 14:54
Tx date 2019-11-07
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Moore, Michael
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other
$
+$348,333 vol
$0.36 each
$487,452
Filed 2019-10-22 12:46
Tx date 2019-10-21
$SR
Strategic Resources Inc.
Moore, Michael Peter
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$60,000
+240,000 vol
$0.25 each
240,000
Filed 2019-10-22 12:45
Tx date 2016-09-09
$SR
Strategic Resources Inc.
Moore, Michael Peter
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2019-10-03 22:28
Tx date 2019-10-02
$VMD
Viemed Healthcare, Inc.
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
47 - Acquisition or disposition by gift

-25,000 vol
1,923,842
Filed 2019-10-02 15:30
Tx date 2019-09-30
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Moore, Michael
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other
$
+$36,967 vol
$0.4467 each
$139,119
Filed 2019-07-03 14:02
Tx date 2019-06-30
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Moore, Michael
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other
$
+$39,114 vol
$0.4358 each
$102,152
Filed 2019-04-23 17:58
Tx date 2016-09-09
$STI
Strategic Resources Inc.
Moore, Michael Peter
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
900,000
Filed 2019-04-05 10:12
Tx date 2019-03-31
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Moore, Michael
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other
$
+$18,531 vol
$0.92 each
$63,038
Filed 2019-02-25
Tx date 2019-02-25
$ONC
Oncolytics Biotech Inc.
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
52,893
Filed 2019-02-25
Tx date 2019-02-25
$ONC
Oncolytics Biotech Inc.
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2019-02-25
Tx date 2019-02-25
$ONC
Oncolytics Biotech Inc.
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
5,105
Filed 2019-02-25
Tx date 2019-02-25
$ONC
Oncolytics Biotech Inc.
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
Rights Performance Share Units
00 - Opening Balance-Initial SEDI Report
4,210
Filed 2019-01-21
Tx date 2019-01-17
$VMD
Viemed Healthcare, Inc.
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+207,226 vol
387,765
Filed 2019-01-11
Tx date 2019-01-04
$VMD
Viemed Healthcare, Inc.
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$542,859
+99,243 vol
$5.47 each
1,980,650
Filed 2019-01-11
Tx date 2019-01-04
$VMD
Viemed Healthcare, Inc.
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-99,243 vol
198,486
Filed 2019-01-11
Tx date 2019-01-04
$VMD
Viemed Healthcare, Inc.
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$173,989
+31,808 vol
$5.47 each
Filed 2019-01-11
Tx date 2019-01-04
$VMD
Viemed Healthcare, Inc.
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-31,808 vol
Filed 2019-01-09
Tx date 2019-01-04
$VMD
Viemed Healthcare, Inc.
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$173,989
+31,808 vol
$5.47 each
1,913,215
Filed 2019-01-09
Tx date 2019-01-04
$VMD
Viemed Healthcare, Inc.
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-173,989.76
-31,808 vol
$5.47 each
1,881,407
Filed 2019-01-09
Tx date 2019-01-04
$VMD
Viemed Healthcare, Inc.
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights

-31,808 vol
265,921
Filed 2019-01-02
Tx date 2018-12-28
$VMD
Viemed Healthcare, Inc.
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
47 - Acquisition or disposition by gift
$-195,582.705
-53,511 vol
$3.65 each
1,881,407
Filed 2018-11-23
Tx date 2016-03-04
$PRG
Precipitate Gold Corp.
Moore, Michael Peter
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$24,000
+200,000 vol
$0.12 each
Filed 2018-11-23
Tx date 2018-11-20
$PRG
Precipitate Gold Corp.
Moore, Michael Peter
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$40,000
+500,000 vol
$0.08 each
1,300,000
Filed 2018-11-23
Tx date 2016-03-04
$PRG
Precipitate Gold Corp.
Moore, Michael Peter
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$30,000
+250,000 vol
$0.12 each
600,000
Filed 2018-11-20
Tx date 2018-11-19
$VMD
Viemed Healthcare, Inc.
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$50,193
+11,000 vol
$4.56 each
1,934,918
Filed 2018-11-09
Tx date 2018-11-08
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Moore, Michael
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other
$
+$29,181 vol
$4.26 each
$44,507
Filed 2018-05-18
Tx date 2018-05-17
$VMD
Viemed Healthcare, Inc.
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$43,350
+12,500 vol
$3.47 each
1,923,918
Filed 2018-03-14
Tx date 2018-03-13
$VMD
Viemed Healthcare, Inc.
Moore, Michael
5 - Senior Officer of Issuer
Holder: Gregory Crawford (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market

-3,655,193 vol
0
Filed 2018-01-29
Tx date 2017-11-27
$PRG
Precipitate Gold Corp.
Moore, Michael Peter
5 - Senior Officer of Issuer
Direct Ownership
Warrants
55 - Expiration of warrants
$30,800
+77,000 vol
$0.40 each
154,000
Filed 2018-01-10
Tx date 2017-12-21
$VMD
Viemed Healthcare, Inc.
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
Filed 2018-01-10
Tx date 2018-01-04
$VMD
Viemed Healthcare, Inc.
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+130,539 vol
180,539
Filed 2018-01-10
Tx date 2018-01-04
$VMD
Viemed Healthcare, Inc.
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+297,729 vol
297,729
Filed 2018-01-03
Tx date 2017-12-28
$PRG
Precipitate Gold Corp.
Moore, Michael Peter
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,800
+20,000 vol
$0.09 each
549,666
Filed 2017-12-23
Tx date 2017-12-21
$VMD
Viemed Healthcare, Inc.
Moore, Michael
4 - Director of Issuer
Holder: Gregory Crawford (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report
3,655,193
Filed 2017-12-23
Tx date 2017-12-21
$VMD
Viemed Healthcare, Inc.
Moore, Michael
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
1,911,418
Filed 2017-12-23
Tx date 2017-12-21
$VMD
Viemed Healthcare, Inc.
Moore, Michael
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
50,000
Filed 2017-11-14
Tx date 2017-11-09
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Moore, Michael
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other
$
+$7,390 vol
$12.18 each
$15,326
Filed 2016-11-15
Tx date 2016-11-09
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Moore, Michael
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other
$90,003
+7,936 vol
$11.34 each
Filed 2016-11-15
Tx date 2016-11-09
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Moore, Michael
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other
$90,003
+7,936 vol
$11.34 each
Filed 2016-11-15
Tx date 2016-11-09
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Moore, Michael
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other
$
+$7,936 vol
$11.34 each
$7,936
Filed 2016-11-15
Tx date 2013-04-09
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Moore, Michael
4 - Director of Issuer
Direct Ownership
Deferred share units
00 - Opening Balance-Initial SEDI Report
Filed 2016-11-14
Tx date 2016-11-09
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Moore, Michael
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other
$90,003
+7,936 vol
$11.34 each
16,567
Filed 2016-10-18
Tx date 2016-10-13
$PRG
Precipitate Gold Corp.
Moore, Michael Peter
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$50,000
+200,000 vol
$0.25 each
750,000
Filed 2016-05-31
Tx date 2016-05-27
$PRG
Precipitate Gold Corp.
Moore, Michael Peter
5 - Senior Officer of Issuer
Direct Ownership
Warrants
55 - Expiration of warrants
$-17,500
-70,000 vol
$0.25 each
77,000
Filed 2016-03-09
Tx date 2016-03-04
$PRG
Precipitate Gold Corp.
Moore, Michael Peter
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$24,000
+200,000 vol
$0.12 each
550,000
Filed 2015-11-20
Tx date 2015-11-19
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Moore, Michael
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other
$39,993
+2,069 vol
$19.33 each
8,631
Filed 2015-11-17
Tx date 2015-11-06
$OEG
ONEnergy Inc.
Moore, Michael John
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2015-11-17
Tx date 2015-11-17
$OEG
ONEnergy Inc.
Moore, Michael John
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Options
50 - Grant of options
$37,500
+75,000 vol
$0.50 each
75,000
Filed 2015-10-23
Tx date 2015-07-10
$PHM
Patient Home Monitoring Corp.
Moore, Michael
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+500,000 vol
500,000
Filed 2015-10-23
Tx date 2015-07-07
$PHM
Patient Home Monitoring Corp.
Moore, Michael
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2015-08-25
Tx date 2014-11-14
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Moore, Michael
4 - Director of Issuer
Direct Ownership
Units Deferred Share Units
37 - Stock split or consolidation
$-40,000.03
-143,885 vol
$0.278 each
Filed 2015-08-25
Tx date 2015-06-16
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Moore, Michael
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other
$10,003
+340 vol
$29.42 each
6,562
Filed 2015-08-25
Tx date 2015-05-27
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Moore, Michael
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other
$39,992
+1,426 vol
$28.05 each
6,222
Filed 2015-08-25
Tx date 2014-11-14
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Moore, Michael
4 - Director of Issuer
Direct Ownership
Deferred share units
37 - Stock split or consolidation
$39,998
+4,796 vol
$8.34 each
4,796
Filed 2015-08-25
Tx date 2013-04-09
$TR
Stem Cell Therapeutics Corp.
Moore, Michael
4 - Director of Issuer
Direct Ownership
Units Deferred Share Units
00 - Opening Balance-Initial SEDI Report
Filed 2015-08-25
Tx date 2014-05-27
$TR
Stem Cell Therapeutics Corp.
Moore, Michael
4 - Director of Issuer
Direct Ownership
Units Deferred Share Units
97 - Other
$40,000
+143,885 vol
$0.278 each
Filed 2015-08-25
Tx date 2013-04-09
$TR
Stem Cell Therapeutics Corp.
Moore, Michael
4 - Director of Issuer
Direct Ownership
Units Deferred Share Units
00 - Opening Balance-Initial SEDI Report
Filed 2015-08-25
Tx date 2014-05-27
$TR
Stem Cell Therapeutics Corp.
Moore, Michael
4 - Director of Issuer
Direct Ownership
Units Deferred Share Units
97 - Other
$40,000
+143,885 vol
$0.278 each
Filed 2015-08-25
Tx date 2015-06-16
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Moore, Michael
4 - Director of Issuer
Direct Ownership
Units Deferred Share Units
97 - Other
$10,003
+340 vol
$29.42 each
Filed 2015-08-25
Tx date 2015-06-16
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Moore, Michael
4 - Director of Issuer
Direct Ownership
Units Deferred Share Units
97 - Other
$10,003
+340 vol
$29.42 each
Filed 2015-08-25
Tx date 2015-05-27
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Moore, Michael
4 - Director of Issuer
Direct Ownership
Units Deferred Share Units
97 - Other
$39,992
+1,426 vol
$28.05 each
Filed 2015-08-25
Tx date 2015-05-27
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Moore, Michael
4 - Director of Issuer
Direct Ownership
Units Deferred Share Units
97 - Other
$39,992
+1,426 vol
$28.05 each
Filed 2015-08-25
Tx date 2014-11-14
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Moore, Michael
4 - Director of Issuer
Direct Ownership
Units Deferred Share Units
37 - Stock split or consolidation
$39,998
+4,796 vol
$8.34 each
Filed 2015-08-25
Tx date 2014-11-14
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Moore, Michael
4 - Director of Issuer
Direct Ownership
Units Deferred Share Units
37 - Stock split or consolidation
$39,998
+4,796 vol
$8.34 each
Filed 2015-08-25
Tx date 2014-11-14
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Moore, Michael
4 - Director of Issuer
Direct Ownership
Units Deferred Share Units
37 - Stock split or consolidation
$-40,000.03
-143,885 vol
$0.278 each
Filed 2015-08-25
Tx date 2014-11-14
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Moore, Michael
4 - Director of Issuer
Direct Ownership
Deferred share units
37 - Stock split or consolidation
$-40,000.03
-143,885 vol
$0.278 each
0
Filed 2015-08-25
Tx date 2014-05-27
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Moore, Michael
4 - Director of Issuer
Direct Ownership
Deferred share units
97 - Other
$40,000
+143,885 vol
$0.278 each
143,885
Filed 2015-08-25
Tx date 2013-04-09
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Moore, Michael
4 - Director of Issuer
Direct Ownership
Deferred share units
00 - Opening Balance-Initial SEDI Report
Filed 2015-07-21
Tx date 2015-07-07
$PHM
Patient Home Monitoring Corp. (formerly International Health Partners Inc.)
Moore, Michael
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
19,114,181
Filed 2015-06-17
Tx date 2015-06-16
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Moore, Michael
4 - Director of Issuer
Direct Ownership
Units Deferred Share Units
97 - Other
$10,003
+340 vol
$29.42 each
6,562
Filed 2015-06-12
Tx date 2015-05-27
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Moore, Michael
4 - Director of Issuer
Direct Ownership
Units Deferred Share Units
97 - Other
$39,992
+1,426 vol
$28.05 each
6,222
Filed 2015-05-22
Tx date 2014-11-14
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Moore, Michael
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-120,000 vol
0
Filed 2015-05-22
Tx date 2014-11-14
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Moore, Michael
4 - Director of Issuer
Direct Ownership
Units Deferred Share Units
37 - Stock split or consolidation
$-40,000.03
-143,885 vol
$0.278 each
0
Filed 2015-05-22
Tx date 2014-11-14
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Moore, Michael
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

+4,000 vol
4,000
Filed 2015-05-22
Tx date 2014-11-14
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Moore, Michael
4 - Director of Issuer
Direct Ownership
Units Deferred Share Units
37 - Stock split or consolidation
$39,998
+4,796 vol
$8.34 each
4,796
Filed 2015-05-20
Tx date 2015-05-16
$PRG
Precipitate Gold Corp.
Moore, Michael Peter
5 - Senior Officer of Issuer
Direct Ownership
Warrants
55 - Expiration of warrants
$-16,149.90
-107,666 vol
$0.15 each
147,000
Filed 2015-05-20
Tx date 2014-05-26
$PRG
Precipitate Gold Corp.
Moore, Michael Peter
5 - Senior Officer of Issuer
Direct Ownership
Warrants
10 - Acquisition or disposition in the public market
$10,500
+70,000 vol
$0.15 each
177,666
Filed 2015-05-20
Tx date 2014-05-26
$PRG
Precipitate Gold Corp.
Moore, Michael Peter
5 - Senior Officer of Issuer
Direct Ownership
Warrants
10 - Acquisition or disposition in the public market
$10,500
+70,000 vol
$0.15 each